Recent pandemic and drug recall events have highlighted the need to transform the pharma supply chain for greater agility and resiliency. Along with the increase in complex drug modalities and the rise of targeted medicines, change is imperative to enhance the supply chain to quickly deliver high quality, safe and effective medicines to consumers.